Effect of Propionate on Mesenteric Adipose Tissue

  • Research type

    Research Study

  • Full title

    Impact of the short chain fatty acid propionate on mesenteric adipose tissue, liver metabolism and insulin sensitivity: The PROMIS study.

  • IRAS ID

    288071

  • Contact name

    Gary Frost

  • Contact email

    g.frost@imperial.ac.uk

  • Sponsor organisation

    Joint Research Compliance Office

  • ISRCTN Number

    ISRCTN11187912

  • Clinicaltrials.gov Identifier

    N/A, N/A

  • Duration of Study in the UK

    2 years, 0 months, 3 days

  • Research summary

    A number of common diseases such as diabetes and heart diseases can result from the body losing the ability to control the levels of sugar and fat in the blood, this is called metabolic disease. Recent research has shown that fat around the waist has a major role in the development of metabolic diseases. The fat that lies between the gut and liver is called mesenteric fat and appears to be very important in the development of metabolic diseases. This is because this collection of fat has a blood flow that goes direly to your liver. Mesenteric fat can release chemical messages that can affect the control of sugar and fat in the blood and have further effect on the liver.\nOur previous research has shown that a chemical made by the bacteria in your gut called propionate has a positive effect on the level of sugar and fat in the blood. One of the potential reasons are propionate could decrease the risks of metabolic disease through regulating the mesenteric fat via receptors expresses on the fat cell. We have developed a special fiber that can increase the propionate in the gut.\nThis study will be a 12-week randomized, placebo controlled, double blind, parallel human study aiming to investigate the effects of the chemical made by the bacteria, propionate, on the function of mesenteric fat. If the project shows positive results this may offer an effective way to prevent a number of metabolic diseases related to high levels of sugar or fat in the blood such as diabetes and heart diseases.\n

  • REC name

    London - Riverside Research Ethics Committee

  • REC reference

    20/LO/1297

  • Date of REC Opinion

    25 Jan 2021

  • REC opinion

    Further Information Favourable Opinion